MedPacto, Inc. (235980.KQ)

KRW 4585.0

(-1.4%)

Operating Expenses Summary of MedPacto, Inc.

  • MedPacto, Inc.'s latest annual operating expenses in 2023 was 26.91 Billion KRW , down -23.91% from previous year.
  • MedPacto, Inc.'s latest quarterly operating expenses in 2024 Q2 was 4.72 Billion KRW , down -49.15% from previous quarter.
  • MedPacto, Inc. reported a annual operating expenses of 35.37 Billion KRW in annual operating expenses 2022, up 27.56% from previous year.
  • MedPacto, Inc. reported a annual operating expenses of 27.73 Billion KRW in annual operating expenses 2021, up 5.21% from previous year.
  • MedPacto, Inc. reported a quarterly operating expenses of 9.28 Billion KRW for 2024 Q1, up 28.8% from previous quarter.
  • MedPacto, Inc. reported a quarterly operating expenses of 7.2 Billion KRW for 2023 Q4, up 25.24% from previous quarter.

Annual Operating Expenses Chart of MedPacto, Inc. (2023 - 2017)

Historical Annual Operating Expenses of MedPacto, Inc. (2023 - 2017)

Year Operating Expenses Operating Expenses Growth
2023 26.91 Billion KRW -23.91%
2022 35.37 Billion KRW 27.56%
2021 27.73 Billion KRW 5.21%
2020 26.36 Billion KRW 112.55%
2019 12.4 Billion KRW 24.38%
2018 9.97 Billion KRW 225.49%
2017 3.06 Billion KRW 0.0%

Peer Operating Expenses Comparison of MedPacto, Inc.

Name Operating Expenses Operating Expenses Difference
HLB Co., Ltd. 109.98 Billion KRW 75.525%
iNtRON Biotechnology, Inc. 7.84 Billion KRW -243.105%
BINEX Co., Ltd. 55.67 Billion KRW 51.65%
Bioneer Corporation 204.55 Billion KRW 86.84%
Anterogen.Co.,Ltd. 7.74 Billion KRW -247.787%
MEDIPOST Co., Ltd. 65.31 Billion KRW 58.785%
CrystalGenomics, Inc. 32.36 Billion KRW 16.838%
Helixmith Co., Ltd 37.36 Billion KRW 27.96%
Chabiotech Co.,Ltd. 285.93 Billion KRW 90.586%
Medy-Tox Inc. 110.88 Billion KRW 75.723%
Peptron, Inc. 16.65 Billion KRW -61.614%
Amicogen, Inc. 52.82 Billion KRW 49.039%
Genexine, Inc. 41.62 Billion KRW 35.334%
HLB Therapeutics Co.,Ltd. 16.16 Billion KRW -66.514%
LegoChem Biosciences, Inc. 98.61 Billion KRW 72.704%
ALTEOGEN Inc. 40.93 Billion KRW 34.239%
PharmaResearch Co., Ltd. 89.44 Billion KRW 69.903%
SillaJen, Inc. 5.11 Billion KRW -426.567%
JETEMA, Co., Ltd. 25.66 Billion KRW -4.89%
OliX Pharmaceuticals,Inc 35.24 Billion KRW 23.632%
Genomictree Inc. 16.26 Billion KRW -65.506%
D&D Pharmatech 32.16 Billion KRW 16.304%
EASY BIO,Inc. 29.67 Billion KRW 9.277%
GI Innovation, Inc. 57.59 Billion KRW 53.259%